Inventor · disambiguated record
William Joseph Lambert
Also filed as: LAMBERT WILLIAM · LAMBERT WILLIAM J · LAMBERT WILLIAM JOSEPH
13 granted patents·5 pending applications·280 citations·filing 1995–2023
91Inventor score
Top patents by PatentIndex Score
18 records- 0192US10617642B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Apr 14, 2020·9 cites·20 claims
- 0292US6284727B1Prolonged delivery of peptidesSCIOS INC·Filed 1995·Granted Sep 4, 2001·178 cites·37 claims
- 0391US6828303B2Prolonged delivery of peptidesSCIOS INC·Filed 2001·Granted Dec 7, 2004·54 cites·48 claims
- 0484US10729651B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Aug 4, 2020·2 cites·14 claims
- 0583US10675245B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Jun 9, 2020·2 cites·19 claims
- 0682US11628217B2Highly concentrated low viscosity MASP-2 inhibitory antibody formulations, kits, and methodsOMEROS CORP·Filed 2017·Granted Apr 18, 2023·2 cites·28 claims
- 0782US9770414B2Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agentGARCIA LOUIE DANIEL·Filed 2010·Granted Sep 26, 2017·13 cites·65 claims
- 0877US10123974B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Nov 13, 2018·2 cites·14 claims
- 0977US9974744B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted May 22, 2018·2 cites·20 claims
- 1077US6643950B2System and method for measuring freeze dried cake resistanceEISAI CO LTD·Filed 2001·Granted Nov 11, 2003·16 cites·19 claims
- 1173US2024247078A1Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods of treating subjects suffering from atypical hemolytic syndromeOMEROS CORP·Filed 2023·Application pending·0 cites
- 1271US2023226178A1Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methodsOMEROS CORP·Filed 2023·Application pending·0 cites
- 1362US2006003918A1Prolonged delivery of peptidesKIM YESOOK·Filed 2004·Application pending·0 cites
- 1461US10610486B2Sustained release formulation of a non-steroidal anti-inflammatory drugGARCIA LOUIE DANIEL·Filed 2011·Granted Apr 7, 2020·0 cites·19 claims
- 1554US2019062455A1Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods of treating subjects suffering from atypical hemolytic syndromeOMEROS CORP·Filed 2018·Application pending·0 cites
- 1651US10028911B2Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agentPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Jul 24, 2018·0 cites·24 claims
- 1750US11767302B2Reagents and methods for tetrazine synthesisUNIV DELAWARE·Filed 2021·Granted Sep 26, 2023·0 cites·21 claims
- 1835US2010305500A1Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agentPACIRA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →